Biotechnology · Healthcare
CFO, Chief Accounting Officer
2025-09-02–present
Chief Accounting Officer
Opus Genetics, Inc. (IRD)Equibles does not estimate personal net worth.
Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRD alertsRobert Gagnon is recorded as Chief Accounting Officer at Opus Genetics, Inc. (IRD) since September 2, 2025 and CFO at Opus Genetics, Inc. (IRD). The newest filing on record that lists Robert Gagnon as CFO at Opus Genetics, Inc. (IRD) is dated March 23, 2026. Opus Genetics, Inc. reported in an 8-K filed September 2, 2025 that Robert Gagnon was appointed Chief Financial Officer and principal accounting officer, effective September 2, 2025. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.
“On August 29, 2025, Opus Genetics, Inc., a Delaware corporation (the "Company"), appointed Robert Gagnon as the Company's Chief Financial Officer and principal accounting officer, effective September 2, 2025 (the "Effective Date").”
2025-09-02–present
Start not stated–present
Last confirmed March 23, 2026
Biotechnology · Healthcare
CFO, Chief Accounting Officer
2025-09-02–present